ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide

C66H85F6N15O9 — CID 159384705

IUPACethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide
SMILESCC(C)c1nnc([C@H]2CC[C@@H](C(=O)CCCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)N(C)C2)o1.CC(C)c1nnc([C@H]2CC[C@H](C(=O)CCCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)N(C)C2)o1.CCOC(=O)[C@H]1CC[C@H](c2nnc(C(C)C)o2)CN1C
InChIInChI=1S/2C26H31F3N6O3.C14H23N3O3/c2*1-16(2)24-31-32-25(38-24)17-11-12-20(34(3)14-17)21(36)10-7-13-30-23(37)19-15-35(18-8-5-4-6-9-18)33-22(19)26(27,28)29;1-5-19-14(18)11-7-6-10(8-17(11)4)13-16-15-12(20-13)9(2)3/h2*4-6,8-9,15-17,20H,7,10-14H2,1-3H3,(H,30,37);9-11H,5-8H2,1-4H3/t17-,20+;17-,20-;10-,11+/m000/s1
InChIKeyLLISIKYMLILVCB-VVGNCOQASA-N
MW1346.49 g/mol
LogP10.64
Rot. Bonds22

About ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide

ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide (PubChem CID 159384705) has the molecular formula C66H85F6N15O9 and a molecular weight of 1346.49 g/mol. Its IUPAC name is ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide.

Molecular Properties

Compound Nameethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide
PubChem CID159384705
Molecular FormulaC66H85F6N15O9
Molecular Weight1346.49 g/mol
Exact Mass1345.66
IUPAC Nameethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide
SMILESCC(C)c1nnc([C@H]2CC[C@@H](C(=O)CCCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)N(C)C2)o1.CC(C)c1nnc([C@H]2CC[C@H](C(=O)CCCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)N(C)C2)o1.CCOC(=O)[C@H]1CC[C@H](c2nnc(C(C)C)o2)CN1C
InChIInChI=1S/2C26H31F3N6O3.C14H23N3O3/c2*1-16(2)24-31-32-25(38-24)17-11-12-20(34(3)14-17)21(36)10-7-13-30-23(37)19-15-35(18-8-5-4-6-9-18)33-22(19)26(27,28)29;1-5-19-14(18)11-7-6-10(8-17(11)4)13-16-15-12(20-13)9(2)3/h2*4-6,8-9,15-17,20H,7,10-14H2,1-3H3,(H,30,37);9-11H,5-8H2,1-4H3/t17-,20+;17-,20-;10-,11+/m000/s1
InChIKeyLLISIKYMLILVCB-VVGNCOQASA-N
XLogP10.64
TPSA280.76 Ų
H-Bond Donors2
H-Bond Acceptors22
Rotatable Bonds22
Heavy Atoms96
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001346.49
LogP ≤ 510.64
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide?
The IUPAC name of ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide (CID 159384705) is ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide.
What is the SMILES notation for ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide?
The canonical SMILES for ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide is CC(C)c1nnc([C@H]2CC[C@@H](C(=O)CCCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)N(C)C2)o1.CC(C)c1nnc([C@H]2CC[C@H](C(=O)CCCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)N(C)C2)o1.CCOC(=O)[C@H]1CC[C@H](c2nnc(C(C)C)o2)CN1C.
What is the InChIKey of ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide?
The InChIKey is LLISIKYMLILVCB-VVGNCOQASA-N. The full InChI is InChI=1S/2C26H31F3N6O3.C14H23N3O3/c2*1-16(2)24-31-32-25(38-24)17-11-12-20(34(3)14-17)21(36)10-7-13-30-23(37)19-15-35(18-8-5-4-6-9-18)33-22(19)26(27,28)29;1-5-19-14(18)11-7-6-10(8-17(11)4)13-16-15-12(20-13)9(2)3/h2*4-6,8-9,15-17,20H,7,10-14H2,1-3H3,(H,30,37);9-11H,5-8H2,1-4H3/t17-,20+;17-,20-;10-,11+/m000/s1.
What are the key properties of ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide?
ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide has a molecular weight of 1346.49 g/mol, XLogP of 10.64, 22 rotatable bonds, 2 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl (2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidine-2-carboxylate;N-[4-[(2R,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide;N-[4-[(2S,5S)-1-methyl-5-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)piperidin-2-yl]-4-oxobutyl]-1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxamide is sourced from PubChem (CID 159384705), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).